期刊文献+

骨质疏松相关信号通路研究进展 被引量:28

Research progress of signaling pathways in osteoporosis
下载PDF
导出
摘要 骨代谢过程包括骨形成及骨吸收,当两者间的平衡被打破后便会出现骨硬化或者骨量减少甚至骨质疏松,其具体的分子调节通路不明。现代研究表明,在骨代谢过程中至少存在RANKL/RANK/OPG信号通路、Wnt/β-catenin信号通路、PTH信号通路、PPAR-γ信号通路等,各个通路间还存在交叉。通过分子信号通路,可有效促进骨代谢研究,并开发具有治疗骨质疏松的新药。 Bone metabolism consists of bone formation and bone resorption osteopenia, or even osteoporosis, but the specific signal pathway remains The imbalance between them causes osteosclerosis, unknown. Current researches reveal that at least 4 signaling pathways participate in bone metabolism: RANKL/RANK/OPG signaling pathway, Wnt/β-catenin signaling pathway, PTH signaling pathway, and PPAR-γ, signaling pathway. And the cross-talks exist between pathways. Through the signaling pathways, we can promote the study of bone metabolism and develop new drugs to treat osteoporosis.
作者 查小云 胡予
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第2期205-209,共5页 Chinese Journal of Osteoporosis
关键词 骨质疏松 信号通路 RANKL/RANK/OPG信号通路 Wnt/β-catenin信号通路 PTH信号通路 PPAR-γ信号通路 Osteoporosis Signaling pathway RANKL/RANK/OPG signaling pathway Wnt/β-catenin signaling pathway PTHsignaling pathway PPAR-γ signaling pathway
  • 相关文献

参考文献47

  • 1Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis[ J ]. Endocrine Reviews, 2000,21 (2) : 115-137.
  • 2Karin M, Gmten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression [ J ] . Nat Rev Immunol, 2005,5(10) :749-759.
  • 3Courtois G, Gilmore T D. Mutations in the NF-kappaB signaling pathway: implications for human disease [ J ]. Oneogene, 2006, 25 (51) :6831-6843.
  • 4Laeey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J]. Cell, 1998,93(2):165-176.
  • 5Asanuma Y, Chung CP, Oeser A, et al. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis [ J ]. Atherosclerosis, 2007,195 ( 2 ) : e1 35-e141.
  • 6Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [ J]. J Bone Miner Res, 2000,15 (1) :2-12.
  • 7Douni E, Rinotas V, Makrinou E, et al. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF[ J]. Hum Mol Genet, 2012,21 (4) :784-798.
  • 8Amizuka N, Shimomura I, Li M, et al. Defective bone remodelling in osteoprotegerin-deficient mice [ J ]. J Electron Microsc ( Tokyo), 2003,52 ( 6 ) :503-513.
  • 9Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution [ J ]. Annu Rev Immunol, 2002,20:795-823.
  • 10Darnay BG, Besse A, Poblenz AT, et al. TRAFs in RANK signaling[ J]. Adv Exp Med Biol, 2007,597:152-159.

同被引文献389

引证文献28

二级引证文献294

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部